Login / Register
MS Validated Antibodies - Logo
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
  • About us
  • Products
    • Primary antibodies
    • Gallery
  • Distributors
  • Validation
    • Tissue Microarrays
  • Publications
    • Large Scale Studies
    • Further Publications
    • Events
    • Quiz
  • Contact
×

Cancer Tissue Gallery Melan A+

Path Created with Sketch.
Go to Melan A+ Normal Tissue GalleryGo back to Product Page
Adrenal gland - Adrenocortical adenoma showing diffuse strong Melan A+ positivity.
Adrenal gland – Adrenocortical adenoma showing diffuse strong Melan A+ positivity.
Adrenal gland - Adrenocortical carcinoma with diffuse Melan A+ positivity of all tumor cells.
Adrenal gland – Adrenocortical carcinoma with diffuse Melan A+ positivity of all tumor cells.
Breast - Breast cancer of no special type showing diffuse weak Melan A+ immunostaining.
Breast – Breast cancer of no special type showing diffuse weak Melan A+ immunostaining.
Colon - Melan A+ negative colorectal adenocarcinoma.
Colon – Melan A+ negative colorectal adenocarcinoma.
Kidney - Angiomyolipoma with a strong diffuse Melan A+ immunostaining.
Kidney – Angiomyolipoma with a strong diffuse Melan A+ immunostaining.
Kidney - Angiomyolipoma with a weak to moderate Melan A+ immunostaining also involving fat cells.
Kidney – Angiomyolipoma with a weak to moderate Melan A+ immunostaining also involving fat cells.
Kidney - Angiomyolipoma with a weak to moderate Melan A+ positivity.
Kidney – Angiomyolipoma with a weak to moderate Melan A+ positivity.
Kidney - Oncocytoma with moderate Melan A+ immunostaining of tumor cells.
Kidney – Oncocytoma with moderate Melan A+ immunostaining of tumor cells.
Pancreas - Melan A+ negative ductal adenocarcinoma.
Pancreas – Melan A+ negative ductal adenocarcinoma.
Pharynx - Squamous cell carcinoma showing diffuse weak Melan A+ immunostaining.
Pharynx – Squamous cell carcinoma showing diffuse weak Melan A+ immunostaining.
Prostate - Melan A+ negative prostatic adenocarcinoma (Gleason 3+3=6).
Prostate – Melan A+ negative prostatic adenocarcinoma (Gleason 3+3=6).
Skin - Malignant melanoma displaying only a very faint (equivocal) Melan A+ immunostaining in about 50% of tumor cells.
Skin – Malignant melanoma displaying only a very faint (equivocal) Melan A+ immunostaining in about 50% of tumor cells.
Skin - Malignant melanoma showing diffuse strong Melan A+ positivity.
Skin – Malignant melanoma showing diffuse strong Melan A+ positivity.
Skin - Malignant melanoma showing Melan A+ immunostaining of variable intensity in tumor cells (mosaic pattern).
Skin – Malignant melanoma showing Melan A+ immunostaining of variable intensity in tumor cells (mosaic pattern).
Skin - Malignant melanoma with strong Melan A+ positivity in all tumor cells.
Skin – Malignant melanoma with strong Melan A+ positivity in all tumor cells.
Skin - Melan A+ negative basal cell carcinoma containing numerous (non-neoplastic) melanocytes.
Skin – Melan A+ negative basal cell carcinoma containing numerous (non-neoplastic) melanocytes.
Skin - Melan A+ negative squamous cell carcinoma.
Skin – Melan A+ negative squamous cell carcinoma.
Urinary bladder - Muscle-invasive urinary bladder cancer showing weak to moderate Melan A+ immunostaining.
Urinary bladder – Muscle-invasive urinary bladder cancer showing weak to moderate Melan A+ immunostaining.
Urinary bladder - Muscle-invasive urinary bladder cancer with focal weak Melan A+ positivity.
Urinary bladder – Muscle-invasive urinary bladder cancer with focal weak Melan A+ positivity.
  • Linkedin
  • My Account
  • Search
    ×
  • Cart 0
© 2025 MS Validated Antibodies
  • Imprint
  • Privacy Policy
  • Distributors